You are ready to raise capital because your business has momentum, not because it is in trouble. Yet many funding conversations slow down for one simple reason, investors see growth potential, but they do not see enough clarity in the numbers.

That gap matters more than most management teams expect. Investors rarely say no because revenue is too low in absolute terms. They say no because key figures do not explain how your company converts demand into scalable, financeable growth. If you want to understand which metrics investors review before a capital raise, you need to think beyond turnover and EBITDA alone.

• Investors assess quality of growth, not just growth speed.
• Cash conversion often matters as much as profit, especially in expansion phases.
• Customer economics can strengthen or weaken your equity story.
• Working capital pressure is a core issue in capital-intensive growth.
• A strong capital case links numbers to a concrete use of funds.

Why do good companies still struggle in investor conversations?

Many established businesses present historic performance, but investors want forward visibility. They need to understand whether additional capital will accelerate a proven model or simply fund more complexity. The European Central Bank has repeatedly shown in its Survey on the Access to Finance of Enterprises that access to finance depends not only on business performance, but also on how clearly companies present risk, profitability, and funding needs.

If your company generates between 20 and 250 million euros in revenue and plans expansion, a larger inventory build, a new market launch, or an acquisition, your numbers must answer three questions. Is the core business strong, does growth scale efficiently, and will capital create measurable business value within a realistic timeframe?

Which financial metrics do investors review before a capital raise?

Investors usually start with a compact set of operating and financial indicators. They want a clean picture, not fifty slides with every KPI you have ever tracked.

Revenue growth and growth quality

Revenue growth is the entry point, but its composition matters. Investors check whether growth comes from repeat customers, new channels, price increases, geographic expansion, or one-off effects. A health brand in Austria with strong repeat purchase rates looks very different from a business that grows through discounting alone.

Gross margin and contribution margin

Margins show whether your business can absorb scale. If revenue rises while gross margin falls, investors ask whether growth is becoming more expensive. For consumer brands, contribution margin by channel often matters even more, because marketplace, retail, and direct-to-consumer models create very different economics.

EBITDA and operating leverage

EBITDA still matters, but not in isolation. Investors look for signs that fixed costs scale well over time. OECD work on business financing has often highlighted that growth companies face funding friction when profitability exists, but the path from expansion spend to operating return remains unclear.

Cash flow and cash conversion

This is where many capital raises become difficult. A profitable company can still consume large amounts of cash if stock, receivables, or expansion costs rise faster than inflows. Investors want to know how quickly earnings turn into usable liquidity.

Working capital metrics

Days inventory outstanding, days sales outstanding, and days payable outstanding help investors understand how much growth your balance sheet can carry. For a beauty or supplements brand, stock depth and receivables discipline often matter just as much as sales growth.

Customer metrics where relevant

If you have a strong B2C model, investors will often review customer acquisition cost, repeat purchase rate, average order value, retention, and lifetime value. These figures help them judge whether additional marketing capital creates durable growth or only short-lived revenue spikes.

What do investors want to see behind the numbers?

Numbers alone are not enough. Investors look for internal consistency between your KPIs, your strategy, and your capital need. If you want to raise 15 million euros for German expansion, your figures should show what that capital funds, how quickly it is deployed, and which business effect it is expected to unlock.

A convincing data set usually answers these points:

1. Use of funds, what exactly you will finance
2. Timing, when the capital is needed and when results should become visible
3. Sensitivity, what happens if growth is slower, margins tighten, or rollout costs rise
4. Control, how financing supports growth without disrupting strategic freedom more than necessary

That last point is important. Owners and CFOs often focus on price first. Investors often focus on transparency first. yeah, that mismatch kills momentum faster than people admit.

How should you prepare these metrics before approaching investors?

Start with a short investor-ready KPI pack. Keep it simple, but sharp. Your goal is not to impress with volume, it is to reduce uncertainty.

• Build a 12 to 24 month bridge from current performance to the planned growth case
• Separate recurring performance from temporary effects
• Show margin development by channel or business line where relevant
• Map working capital needs directly to expansion steps
• Stress test your liquidity path under base, slower, and faster growth scenarios

For example, a Swiss wellness brand with 40 million euros in revenue may show strong EBITDA, but if expansion into Germany requires a major inventory increase and retail listing fees, investors will focus heavily on working capital planning. A wealth management firm, by contrast, may face less inventory pressure but more upfront cost in talent, compliance, and client acquisition.

Which financing paths fit different KPI profiles?

Not every company with a solid KPI set should choose the same route. Bank debt often suits predictable cash flows and asset-backed growth. Equity investors may fit larger expansion or acquisition plans. Crowdfunding can support brand visibility in some consumer cases, but it rarely replaces a structured capital strategy for larger companies.

In the later evaluation stage, some companies also look at modern digital financing structures, including digital securities in the background, when they want to broaden investor access while keeping the business case at the center. This is where NEVOlink becomes relevant. NEVOlink helps established growth companies access growth capital efficiently, without forcing founders or owners to give up their entrepreneurial vision too early.

The best capital raise is rarely the one with the most exciting narrative. It is the one where your numbers make growth understandable, credible, and actionable. If you want to assess how investor-ready your growth case really is, you can answer a few questions in about 10 minutes in the NEVOlink Simulator and receive a free analysis of your individual Wachstumskapital-Potenzial, the Capital Readiness Report.

---

Dieser Artikel wurde mit Unterstützung von künstlicher Intelligenz (KI) recherchiert und entworfen. Der Inhalt wurde anschließend von unserer Redaktion geprüft, überarbeitet und freigegeben.